Convergence Investment Partners, LLC - NPS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 217 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$1,349,000
-43.4%
51,900
-28.0%
0.18%
-41.1%
Q2 2014$2,382,000
+58.0%
72,087
+43.0%
0.31%
+37.1%
Q1 2014$1,508,000–50,400–0.23%–
 Download
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q4 2014.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders